
XPhyto -CBD:THC Oral/Sublingual Strip
Clinical studies are planned in 2021 to demonstrate the efficient sublingual delivery of a combination of CBD and THC for Multiple Sclerosis-associated spasticity.
Clinical studies are planned in 2021 to demonstrate the efficient sublingual delivery of a combination of CBD and THC for Multiple Sclerosis-associated spasticity.